Lineage Cell Therapeutics
Price & Volume
Stats
See more52W Range | $0.36-$1.72 |
Market Cap | $390.4M |
Shares Short | 27M |
Financials
See moreRevenue (12 Mos) | $10.9M |
Revenue Growth (YoY) | 96.4% |
Gross Profit (12 Mos) | -$2.1M |
Diluted EPS | -$0.17 |
News
See moreYahoo Finance • 7 days ago
Lineage Cell Therapeutics, Inc. (LCTX) Shows Vision Gains in Phase 1/2a OpRegen Trial
Yahoo Finance • 2 months ago
Lineage Cell Revenue Doubles in Q2
Yahoo Finance • 2 months ago
Lineage signals expanded diversification strategy following OpRegen milestones and $42.3M cash position
Yahoo Finance • 2 months ago
Lineage Cell Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
About
CEO | Mr. Brian M. Culley M.A., M.B.A. |
CFO | Ms. Jill Ann Howe |
Address | 2173 Salk Avenue, Carlsbad, CA, United States, 92008 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 70 |
